Clinical Use of Continuous Glucose Monitoring in Pediatrics.
作者信息
Lal Rayhan A, Maahs David M
机构信息
1 Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine , Stanford, California.
2 Division of Endocrinology, Department of Medicine, Stanford University School of Medicine , Stanford, California.
出版信息
Diabetes Technol Ther. 2017 May;19(S2):S37-S43. doi: 10.1089/dia.2017.0013.
Abstract
摘要
相似文献
1
Clinical Use of Continuous Glucose Monitoring in Pediatrics.
Diabetes Technol Ther. 2017 May;19(S2):S37-S43. doi: 10.1089/dia.2017.0013.
2
Continuous Glucose Monitoring for the Internist.
Med Clin North Am. 2021 Nov;105(6):967-982. doi: 10.1016/j.mcna.2021.06.004. Epub 2021 Sep 9.
3
Self-Monitoring of Blood Glucose.
Diabetes Technol Ther. 2019 Feb;21(S1):S4-S12. doi: 10.1089/dia.2019.2501.
4
Self-Monitoring of Blood Glucose.
Diabetes Technol Ther. 2018 Feb;20(S1):S3-S12. doi: 10.1089/dia.2018.2501.
5
The problem with ADAGE (A1c-derived average glucose equivalent).
MedGenMed. 2007 Nov 27;9(4):43.
6
Efficacy and reliability of the continuous glucose monitoring system.
Diabetes Technol Ther. 2000;2 Suppl 1:S19-26. doi: 10.1089/15209150050214087.
7
Benefits of short-term professional continuous glucose monitoring in clinical practice.
Diabetes Technol Ther. 2013 Sep;15(9):744-7. doi: 10.1089/dia.2013.0027. Epub 2013 Jun 20.
8
Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany.
Exp Clin Endocrinol Diabetes. 2018 Jul;126(7):411-428. doi: 10.1055/a-0586-5302. Epub 2018 Jul 5.
9
Standardization of self-monitoring of blood glucose and continuous glucose monitoring reporting.
Diabetes Technol Ther. 2013 Mar;15(3):193. doi: 10.1089/dia.2013.0055. Epub 2013 Mar 1.
10
Monitoring glycemia in diabetes.
Med Clin North Am. 2015 Jan;99(1):35-45. doi: 10.1016/j.mcna.2014.08.017. Epub 2014 Oct 16.
引用本文的文献
1
Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin A1c in pediatric patients on sensor-augmented pump therapy.
Front Endocrinol (Lausanne). 2024 Jun 18;15:1388245. doi: 10.3389/fendo.2024.1388245. eCollection 2024.
2
Management of Neonatal Diabetes due to a Mutation with Automated Insulin Delivery System and Remote Patient Monitoring.
Case Rep Endocrinol. 2023 Aug 23;2023:8825724. doi: 10.1155/2023/8825724. eCollection 2023.
3
Improved Glycemic Control Observed in Children with Type 1 Diabetes Following the Introduction of Smart Insulin Pens: A Real-World Study.
Diabetes Ther. 2022 Jan;13(1):43-56. doi: 10.1007/s13300-021-01177-w. Epub 2021 Nov 8.
4
The Quality of Life and Satisfaction with Continuous Glucose Monitoring Therapy in Children under 7 Years of Age with T1D Using the rtCGM System Integrated with Insulin Pump-A Caregivers Point of View.
Sensors (Basel). 2021 May 25;21(11):3683. doi: 10.3390/s21113683.
5
Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies.
J Diabetes Investig. 2020 Nov;11(6):1388-1402. doi: 10.1111/jdi.13290. Epub 2020 Jul 7.
6
Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?
J Diabetes Complications. 2020 Apr;34(4):107513. doi: 10.1016/j.jdiacomp.2019.107513. Epub 2019 Dec 30.
7
Type 1 diabetes mellitus management in young children: implementation of current technologies.
Pediatr Res. 2020 Mar;87(4):624-629. doi: 10.1038/s41390-019-0665-4. Epub 2019 Nov 12.
8
Estimating plasma glucose with the FreeStyle Libre Pro continuous glucose monitor during oral glucose tolerance tests in youth without diabetes.
Pediatr Diabetes. 2019 Dec;20(8):1072-1079. doi: 10.1111/pedi.12910. Epub 2019 Aug 29.
9
Update on biomarkers of glycemic control.
World J Diabetes. 2019 Jan 15;10(1):1-15. doi: 10.4239/wjd.v10.i1.1.
10
Glucosuria and all-cause mortality among general screening participants.
Clin Exp Nephrol. 2018 Aug;22(4):850-859. doi: 10.1007/s10157-017-1528-0. Epub 2018 Jan 12.
本文引用的文献
1
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30.
2
Tight Glycemic Control in Critically Ill Children.
N Engl J Med. 2017 Feb 23;376(8):729-741. doi: 10.1056/NEJMoa1612348. Epub 2017 Jan 24.
3
6. Glycemic Targets.
Diabetes Care. 2017 Jan;40(Suppl 1):S48-S56. doi: 10.2337/dc17-S009.
4
Medtronic automated insulin delivery device gets FDA nod.
Nat Biotechnol. 2016 Dec 7;34(12):1220. doi: 10.1038/nbt1216-1220.
5
Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population.
Pediatr Diabetes. 2017 Nov;18(7):622-628. doi: 10.1111/pedi.12474. Epub 2016 Nov 23.
6
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
Diabetes Care. 2017 Jan;40(1):63-68. doi: 10.2337/dc16-1525. Epub 2016 Nov 4.
7
Continuous glucose monitoring and HbA1c in the evaluation of glucose metabolism in children at high risk for type 1 diabetes mellitus.
Diabetes Res Clin Pract. 2016 Oct;120:89-96. doi: 10.1016/j.diabres.2016.07.027. Epub 2016 Aug 6.
8
Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress.
J Diabetes Sci Technol. 2016 Jun 28;10(4):852-8. doi: 10.1177/1932296816650900. Print 2016 Jul.
9
Automated integration of continuous glucose monitor data in the electronic health record using consumer technology.
J Am Med Inform Assoc. 2016 May;23(3):532-7. doi: 10.1093/jamia/ocv206. Epub 2016 Mar 27.
10
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.
Endocr Pract. 2016 Feb;22(2):231-61. doi: 10.4158/EP151124.CS. Epub 2016 Jan 27.
Zotero 插件